CVS HEALTH Corp — Form 10-Q

CVS Health executed the Fourth Amendment to its Five Year Credit Agreement on May 22, 2026, with Bank of America as administrative agent and 17+ lenders including Barclays, Citi, Goldman Sachs, JPMorgan, Wells Fargo, and others. The $2.5 billion revolving credit facility and $250 million letter of credit sub-facility remain unchanged in size. The amendment restated the entire credit agreement and updated standard terms including pricing levels, definitions related to SOFR transition, and compliance mechanics. No specific material terms were altered; this appears to be primarily a technical amendment to accommodate standard updates and maintain operational flexibility.